China's Proposed IP Law Changes May Drive Pharma Innovation

By David Vondle

Despite the geopolitical environment and the high-technology industry obtaining much of the attention from governments and media in the U.S. and China, a fast-growing pharmaceutical and life sciences industry exists in China, particularly early-stage pharmaceutical companies seeking additional capital and partners for R&D.